Genmab A/SvsUnitedHealth

GMAB and UNH stock compared: price, dividend, valuation and results, from SEC filings.

UNH

UnitedHealth Group Incorporated

$339.85

Value $308B

+2.84%
UNH's page

Genmab A/S (GMAB) has a market value of $32.5B and UnitedHealth (UNH) $308B. Over the last year, with dividends, GMAB moved +65.5% and UNH +12.9%. The P/E is 33.8 for GMAB and 19.4 for UNH. Dividend yield: GMAB none, UNH 2.67%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    GMAB$32.5B

    UNH$308B

    UNH is 9.5 times GMAB

  • Revenue, 12 months

    GMAB$3.7B

    UNH$450B

    UNH is 121 times GMAB

  • Net income, 12 months

    GMAB$963M

    UNH$15.9B

    UNH is 16 times GMAB

  • Operating margin

    GMAB28.6%

    UNH5.3%

    23.3 points apart

  • ROIC

    GMAB7.8%

    UNH11.3%

    3.5 points apart

  • P/E

    GMAB33.8

    UNH19.4

    GMAB is 1.7 times UNH

  • Dividend yield

    GMAB0.0%

    UNH2.7%

    2.7 points apart

  • 5-year return

    GMAB+22.0%

    UNH-15.4%

    37.4 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

GMAB+22.0%

UNH-15.4%

5010015020222023202420252026
Returns by period
PeriodGMABWith dividendsUNHWith dividends
1 year since November 19, 2025+65.5%Price +65.5%+12.9%Price +10.0%
3 years since November 20, 2023+55.9%+15.9% a yearPrice +55.9%-32.4%-12.2% a yearPrice -36.5%
5 years since November 19, 2021+22.0%+4.1% a yearPrice +22.0%-15.4%-3.3% a yearPrice -22.8%
10 years since November 21, 2016+177.1%+10.7% a yearPrice +177.1%+166.8%+10.3% a yearPrice +125.9%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

GMABGenmab A/SUNHUnitedHealth

Valuation

GMABUNH
Valuation
Price$50.60$339.85
Market value$32.5B$308B
Enterprise value (EV)$35.9B$354B
P/E33.819.4
P/E, 5-year median4.825.0
P/B5.63.0
EV/EBIT33.814.8
Free cash flow yield3.5%7.4%

Results and growth

GMABUNH
Results and growth
Revenue, 12 months$3.7B$450B
Net income, 12 months$963M$15.9B
Free cash flow, 12 months$1.1B$22.8B
Earnings per share, 12 months$1.54$17.52
Revenue growth, year on year19.2%11.8%
Revenue growth a year, past+24.8%over 2 years+11.7%over 5 years
EPS growth a year, past-51.7%over 2 years-3.8%over 5 years

Margins and returns on capital

GMABUNH
Margins and returns on capital
Gross margin93.6%88.3%
Operating margin28.6%5.3%
Net margin25.9%3.5%
ROIC7.8%11.3%
ROE16.5%15.5%

Balance sheet

GMABUNH
Balance sheet
Cash$1.7B$28.5B
Total debt$5.2B$74.3B
Net debt / EBITDA–1.6
Interest cover4.0×6.2×

Dividends and buybacks

GMABUNH
Dividends and buybacks
Dividend yield–2.7%
Dividend per share, 12 months–$9.06
Dividend growth a year, past–+12.6%over 5 years
Buyback yield1.3%1.8%
Shareholder yield1.3%4.5%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: GMAB or UNH

Didn't find what you were looking for?

Ask us
Which is bigger, Genmab A/S or UnitedHealth?

By market value, UnitedHealth ($308B) is about 9.5 times Genmab A/S ($32.5B), at today's prices.

How did GMAB and UNH stock do over the last 10 years?

Since November 21, 2016, GMAB's price moved +177.1% and UNH's +125.9%. With dividends: GMAB +177.1% (+10.7% a year), UNH +166.8% (+10.3% a year). Past returns do not predict future ones.

Which pays the higher dividend, GMAB or UNH?

The dividend yield at today's price is none for Genmab A/S and 2.67% for UnitedHealth. Over the last twelve months they paid – and $9.06 per share.

What is the P/E of GMAB and UNH?

At today's price, the P/E is 33.8 for GMAB and 19.4 for UNH. The median of the last five years was 4.8 and 25.0, which shows where each stands against its own past.

Which has the higher profit margins, Genmab A/S or UnitedHealth?

Over the last twelve months, the net margin was 25.9% for Genmab A/S and 3.5% for UnitedHealth, and the operating margin 28.6% and 5.3%. Revenue was $3.7B and $450B.

Which is the better investment, Genmab A/S or UnitedHealth?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.